- Home
- TERN vs CMTG Comparison
TERN vs CMTG Comparison
Compare TERN & CMTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- CMTG
- Stock Information
- Founded
- TERN 2017
- CMTG 2015
- Country
- TERN United States
- CMTG United States
- Employees
- TERN N/A
- CMTG N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- CMTG Real Estate Investment Trusts
- Sector
- TERN Health Care
- CMTG Real Estate
- Exchange
- TERN Nasdaq
- CMTG Nasdaq
- Market Cap
- TERN 310.8M
- CMTG 362.3M
- IPO Year
- TERN 2021
- CMTG 2021
- Fundamental
- Price
- TERN $2.90
- CMTG $2.60
- Analyst Decision
- TERN Buy
- CMTG Hold
- Analyst Count
- TERN 5
- CMTG 7
- Target Price
- TERN $15.63
- CMTG $3.81
- AVG Volume (30 Days)
- TERN 1.0M
- CMTG 715.1K
- Earning Date
- TERN 05-08-2025
- CMTG 05-07-2025
- Dividend Yield
- TERN N/A
- CMTG 13.44%
- EPS Growth
- TERN N/A
- CMTG N/A
- EPS
- TERN N/A
- CMTG N/A
- Revenue
- TERN N/A
- CMTG $22,189,000.00
- Revenue This Year
- TERN N/A
- CMTG $1,966.34
- Revenue Next Year
- TERN N/A
- CMTG $11.23
- P/E Ratio
- TERN N/A
- CMTG N/A
- Revenue Growth
- TERN N/A
- CMTG N/A
- 52 Week Low
- TERN $1.87
- CMTG $2.13
- 52 Week High
- TERN $11.40
- CMTG $9.81
- Technical
- Relative Strength Index (RSI)
- TERN 47.68
- CMTG 47.87
- Support Level
- TERN $2.93
- CMTG $2.30
- Resistance Level
- TERN $3.40
- CMTG $2.82
- Average True Range (ATR)
- TERN 0.26
- CMTG 0.18
- MACD
- TERN -0.00
- CMTG 0.05
- Stochastic Oscillator
- TERN 10.89
- CMTG 58.33
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About CMTG Claros Mortgage Trust Inc.
Claros Mortgage Trust Inc is a real estate investment trust. The company is focused mainly on creating a diversified portfolio of income-producing loans collateralized by institutional quality commercial real estate.